Patients with advanced skin cancer to test new mRNA vaccine

Library image. Credit: Getty/Totojang

By Jane Kirby, PA Media

Patients with advanced skin cancer will be able to test a new vaccine as part of a drive to speed up the development of new treatments.

The NHS Cancer Vaccine Launch Pad (CVLP) intends to accelerate access to messenger ribonucleic acid (mRNA) vaccine clinical trials for people with different types of cancer.